Australian Life Sciences Stock News

Ramelius Resources Limited recently confirmed that Deputy Chair and Non-Executive Director Simon Lawson stepped down on June 5, 2026, less than a year after joining the board following the combination with Spartan Resources. At the same time, Ramelius reaffirmed its FY26 production guidance midpoint while lifting all-in sustaining cost estimates, sharpening investor focus on how well the company can control inflationary pressures at its Dalgaranga, Cue, and Mt Magnet operations. We’ll now...

Insiders who acquired AU$702.8k worth of Nido Education Limited's ( ASX:NDO ) stock at an average price of AU$0.62 in...

Even though RAS Technology Holdings Limited ( ASX:RTH ) has fallen by 11% over the past week , insiders who sold...

We feel now is a pretty good time to analyse IRIS Metals Limited's ( ASX:IR1 ) business as it appears the company may...

Whitehaven Coal recently completed the integration of the Blackwater and Daunia metallurgical coal operations, reinforcing its position as a major producer in a structurally elevated price environment. This integration, underpinned by disciplined operations and a solid balance sheet, enhances Whitehaven’s capacity to fund capital returns while maintaining financial resilience. Next, we’ll explore how the successful Blackwater and Daunia integration could reshape Whitehaven Coal’s broader...

Short term share performance context Champion Iron (ASX:CIA) has seen its share price fall over the past week, month and past 3 months, with the stock closing at A$3.96 and a market value of about A$2.2b. Those price moves sit alongside reported annual revenue of A$1,769.7m, net income of A$168.7m and a value score of 5, providing a base set of numbers to help you assess the current share price. See our latest analysis for Champion Iron. Looking beyond the recent weakness, with a 30 day share...

In recent days, Evolution Mining reported a record statutory profit for the first half of FY26 and declared a fully franked interim dividend, while also highlighting growth projects such as the Cowal underground and Mungari discoveries ahead of its June-quarter update. However, renewed inflation concerns and the prospect of further U.S. interest rate hikes have weighed on gold prices, raising fresh questions about how resilient Evolution's cash flow expectations will be if bullion remains...

Investors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks...

In early June 2026, Visage Imaging, a wholly owned subsidiary of Pro Medicus, announced past demonstrations of its AI‑optimized One Platform and Visage 7.1.20 Enterprise Imaging Platform at the SIIM 2026 annual meeting, highlighting new Apple ecosystem support, digital pathology viewing and AI‑optimized radiology reporting. A particularly interesting aspect is that the Visage 7 | Reporting module, designed to improve workflow efficiency and diagnostic precision, is expected to go live across...

Tamboran Resources Corporation recently filed a Shelf Registration for a potential US$30.04 million offering of 844,605 common shares linked to its ESOP, signaling plans to raise capital over time rather than in a single transaction. This filing highlights how Tamboran is keeping funding options open for its Beetaloo Basin ambitions while investors weigh the trade-off between potential dilution and project advancement. We will now examine how this ESOP-related shelf registration shapes...

As Australian shares follow Wall Street into the red, with geopolitical tensions and economic uncertainties casting a shadow over market sentiment, investors are increasingly seeking refuge in more stable sectors like consumer staples. In such volatile times, growth companies with high insider ownership can offer a compelling investment narrative as they often signal strong confidence from those who know the business best.

In the midst of a challenging period for Australian shares, with market sentiment swayed by geopolitical tensions and economic uncertainties, investors are increasingly on the lookout for opportunities in undervalued stocks. Identifying stocks that may be trading below their estimated value can offer potential upside, especially when broader market volatility prompts a shift towards more defensive investment strategies.

Australian shares have been under pressure, mirroring Wall Street's downturn amid geopolitical tensions and economic uncertainties. Despite the market's current volatility, investors can still find opportunities by focusing on companies with strong financials and growth potential. Penny stocks, although an older term, continue to represent smaller or newer companies that may offer significant value; we'll explore three such stocks on the ASX that stand out for their financial strength and...

Goodman Group recently reported that data centres made up 73% of its A$14.50 billion development work in progress as at 31 March, and management reiterated its focus on securing global data-centre contracts this calendar year. The update underscores how rapidly Goodman is concentrating its development engine around data-centre infrastructure, signalling a meaningful shift in the composition of its growth projects. We’ll now look at how this intensified data-centre development focus may alter...

Considering whether Waypoint REIT at A$2.48 is offering good value right now, or if the current price already reflects the key risks and rewards. The stock is up 4.6% over the past week and 4.2% over the past month, while the year to date return is a decline of 2.4% and the 1 year return stands at 0.4%. Taken together, this gives a mixed picture of recent performance across different timeframes. Recent coverage around Waypoint REIT has focused on its position within Australian real estate...

With inflation worries, higher global yields and energy shocks back in focus, many investors are looking for stocks backed by solid balance sheets rather than fragile stories. Our Solid Balance Sheet and Fundamentals screener filters for companies with high return on equity, proven past performance and conservative finances. This can help you stay focused on quality when headlines are noisy. In this article, you will see three stocks from this screener that stand out on financial strength and...

Sigma Healthcare (ASX:SIG) is in early discussions to acquire UK pharmacy chain Boots. The talks point to a possible expansion of Sigma’s operations beyond Australia into the UK retail pharmacy market. The potential deal would significantly change Sigma’s global footprint if it proceeds. Sigma Healthcare, which operates as a pharmaceutical wholesaler and pharmacy retail operator in Australia, is now exploring a much larger international role. Boots is a long established UK pharmacy chain,...

New Zealand road contract puts Ventia in focus Ventia Services Group (ASX:VNT) has secured a Road Maintenance and Renewal Services contract with New Zealand’s Far North District Council, valued at about NZ$125 million over an initial five year term. The deal covers the southern road network, with Ventia responsible for pavement, structures, vegetation and roadside assets. It also includes potential three and two year extensions that could extend the relationship beyond the initial period. See...

Cost cutting move and initial share price reaction Woolworths Group (ASX:WOW) has outlined plans to offshore hundreds of corporate roles as part of a A$400 million office cost reduction push. The company aims to support profit margins in a price sensitive consumer setting. The announcement prompted an immediate share price reaction, with Woolworths stock gaining 3.15% on the day. This placed the company’s latest cost program firmly on the radar for investors assessing future earnings...

Woodside Energy Group recently reported that its Scarborough LNG development reached 94% completion, with first cargo now expected in late 2026, marking a major step toward bringing new production capacity online. This progress, alongside management’s emphasis on the project’s potential to materially lift output and free cash flow, is sharpening investor focus on how Woodside’s future earnings mix could evolve as Scarborough ramps up. With Scarborough nearing completion and expected to boost...

Earlier in June 2026, Cochlear lowered its earnings guidance, citing hospital capacity constraints, geopolitical tensions, and reimbursement cuts in China as key headwinds. This revision has sharpened investor focus on how quickly procedure volumes and profit margins can stabilise in the implantable hearing market. We’ll now explore how Cochlear’s guidance downgrade, particularly the impact of China reimbursement cuts, affects the company’s broader investment narrative. Find 10 companies...

Ramsay Health Care recently reported stronger first-half performance in its Australian hospitals and reiterated plans to separate its Ramsay Santé business via an in-specie distribution by the end of 2026, subject to shareholder approval. This combination of improving local hospital operations and a clearer pathway for restructuring its European assets marks an important shift in how the group balances growth and portfolio risk. Next, we will examine how the stronger Australian hospital...

In recent days, Transurban Group reported a FY26 distribution target of A$0.69 per stapled security alongside strong traffic growth across Melbourne, Brisbane, Sydney, and North America, supporting its toll-road income profile. This combination of higher targeted cash distributions and broad-based traffic increases highlights how integral Transurban’s network has become to key urban transport corridors. We’ll now explore how the new FY26 distribution target influences Transurban’s existing...

Amidst a backdrop of geopolitical tensions and fluctuating oil prices, Australian shares are experiencing a downturn, mirroring Wall Street's recent decline. Despite these challenging market conditions, investors continue to seek opportunities in smaller or newer companies that might offer unique value propositions. Penny stocks—though an outdated term—remain relevant for those looking to explore under-the-radar investments with potential financial strength and long-term promise.